Skip to main content
Erschienen in: Diabetologia 2/2009

01.02.2009 | Article

IL-1β-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells

verfasst von: M. L. B. Jacobsen, S. G. Rønn, C. Bruun, C. M. Larsen, D. L. Eizirik, T. Mandrup-Poulsen, N. Billestrup

Erschienen in: Diabetologia | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Chemokines recruit activated immune cells to sites of inflammation and are important mediators of insulitis. Activation of the pro-apoptotic receptor Fas leads to apoptosis-mediated death of the Fas-expressing cell. The pro-inflammatory cytokines IL-1β and IFN-γ regulate the transcription of genes encoding the Fas receptor and several chemokines. We have previously shown that suppressor of cytokine signalling (SOCS)-3 inhibits IL-1β- and IFN-γ-induced nitric oxide production in a beta cell line. The aim of this study was to investigate whether SOCS-3 can influence cytokine-induced Fas and chemokine expression in beta cells.

Methods

Using a beta cell line with inducible Socs3 expression or primary neonatal rat islet cells transduced with a Socs3-encoding adenovirus, we employed real-time RT-PCR analysis to investigate whether SOCS-3 affects cytokine-induced chemokine and Fas mRNA expression. The ability of SOCS-3 to influence the activity of cytokine-responsive Fas and Mcp-1 (also known as Ccl2) promoters was measured by reporter analysis.

Results

IL-1β induced a time-dependent increase in Mcp-1 and Mip-2 (also known as Cxcl2) mRNA expression after 6 h of stimulation in insulinoma (INS)-1 and neonatal rat islet cells. This induction was inhibited when Socs3 was expressed in the cells. In INS-1 cells, IL-1β + IFN-γ induced a tenfold and eightfold increase of Fas mRNA expression after 6 and 24 h, respectively. This induction was inhibited at both time-points when expression of Socs3 was induced. In promoter studies SOCS-3 significantly inhibited the cytokine-induced activity of Mcp-1 and Fas promoter constructs.

Conclusions/interpretation

SOCS-3 inhibits the expression of cytokine-induced chemokine and death-receptor Fas mRNA.
Literatur
1.
Zurück zum Zitat Mandrup-Poulsen T (2001) beta-cell apoptosis: stimuli and signaling. Diabetes 50(Suppl 1):S58–S63PubMedCrossRef Mandrup-Poulsen T (2001) beta-cell apoptosis: stimuli and signaling. Diabetes 50(Suppl 1):S58–S63PubMedCrossRef
2.
Zurück zum Zitat Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T (2008) Cytokine and β-cell biology: from concept to clinical translation. Endo Rev 29:334–350CrossRef Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T (2008) Cytokine and β-cell biology: from concept to clinical translation. Endo Rev 29:334–350CrossRef
3.
Zurück zum Zitat Mandrup-Poulsen T (2003) Apoptotic signal transduction pathways in diabetes. Biochem Pharmacol 66:1433–1440PubMedCrossRef Mandrup-Poulsen T (2003) Apoptotic signal transduction pathways in diabetes. Biochem Pharmacol 66:1433–1440PubMedCrossRef
4.
Zurück zum Zitat Shuai K, Stark GR, Kerr IM, Darnell JE (1993) A single phosphotyrosine residue in Stat91 required for gene activation by interferon-gamma. Science 261:1744–1746PubMedCrossRef Shuai K, Stark GR, Kerr IM, Darnell JE (1993) A single phosphotyrosine residue in Stat91 required for gene activation by interferon-gamma. Science 261:1744–1746PubMedCrossRef
6.
Zurück zum Zitat Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75–84PubMedCrossRef Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75–84PubMedCrossRef
7.
Zurück zum Zitat Moser B, Willimann K (2004) Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis 63(Suppl 2):ii84–ii89PubMedCrossRef Moser B, Willimann K (2004) Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis 63(Suppl 2):ii84–ii89PubMedCrossRef
8.
Zurück zum Zitat Baggiolini M, Dewald B, Moser B (1997) Human chemokines: an update. Annu Rev Immunol 15:675–705PubMedCrossRef Baggiolini M, Dewald B, Moser B (1997) Human chemokines: an update. Annu Rev Immunol 15:675–705PubMedCrossRef
9.
Zurück zum Zitat Olson TS, Ley K (2002) Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283:R7–R28PubMed Olson TS, Ley K (2002) Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283:R7–R28PubMed
10.
11.
Zurück zum Zitat Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44:325–332PubMedCrossRef Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44:325–332PubMedCrossRef
12.
Zurück zum Zitat Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50:909–920PubMedCrossRef Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50:909–920PubMedCrossRef
13.
Zurück zum Zitat Karlsen AE, Heding PE, Frobose H et al (2004) Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways. Diabetologia 47:1998–2011PubMedCrossRef Karlsen AE, Heding PE, Frobose H et al (2004) Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1beta-mediated toxicity through inhibition of multiple nuclear factor-kappaB-regulated proapoptotic pathways. Diabetologia 47:1998–2011PubMedCrossRef
14.
Zurück zum Zitat Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276:48879–48886PubMedCrossRef Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276:48879–48886PubMedCrossRef
15.
Zurück zum Zitat Garcia GE, Xia YY, Chen SZ et al (2000) NF-kappa B-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1 beta, TNF-alpha, and LPS. J Leukoc Biol 67:577–584PubMed Garcia GE, Xia YY, Chen SZ et al (2000) NF-kappa B-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1 beta, TNF-alpha, and LPS. J Leukoc Biol 67:577–584PubMed
16.
Zurück zum Zitat Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA (1998) Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 275:G269–G278PubMed Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA (1998) Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 275:G269–G278PubMed
17.
Zurück zum Zitat Imaizumi Y, Sugita S, Yamamoto K et al (2002) Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway. Int Immunol 14:147–155PubMedCrossRef Imaizumi Y, Sugita S, Yamamoto K et al (2002) Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 alpha/CCL20 gene transcription via the NF-kappa B pathway. Int Immunol 14:147–155PubMedCrossRef
18.
Zurück zum Zitat Stassi G, De-Maria R, Trucco G et al (1997) Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193–1200PubMedCrossRef Stassi G, De-Maria R, Trucco G et al (1997) Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193–1200PubMedCrossRef
19.
Zurück zum Zitat Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K (1996) Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306–1312PubMedCrossRef Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K (1996) Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306–1312PubMedCrossRef
22.
23.
Zurück zum Zitat Stassi G, Todaro M, Richiusa P et al (1995) Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. Transplant Proc 27:3271–3275PubMed Stassi G, Todaro M, Richiusa P et al (1995) Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. Transplant Proc 27:3271–3275PubMed
24.
Zurück zum Zitat Su X, Hu Q, Kristan JM et al (2000) Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 164:2523–2532PubMed Su X, Hu Q, Kristan JM et al (2000) Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 164:2523–2532PubMed
25.
Zurück zum Zitat Dudek NL, Thomas HE, Mariana L et al (2006) Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 55:2412–2418PubMedCrossRef Dudek NL, Thomas HE, Mariana L et al (2006) Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 55:2412–2418PubMedCrossRef
26.
Zurück zum Zitat Allison J, Thomas HE, Catterall T, Kay TW, Strasser A (2005) Transgenic expression of dominant-negative fas-associated death domain protein in β cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice. J Immunol 175:293–301PubMed Allison J, Thomas HE, Catterall T, Kay TW, Strasser A (2005) Transgenic expression of dominant-negative fas-associated death domain protein in β cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice. J Immunol 175:293–301PubMed
27.
Zurück zum Zitat Kim S, Kim KA, Hwang DY et al (2000) Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J Immunol 164:2931–2936PubMed Kim S, Kim KA, Hwang DY et al (2000) Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J Immunol 164:2931–2936PubMed
28.
Zurück zum Zitat Kim YH, Kim S, Kim KA et al (1999) Apoptosis of pancreatic B cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29:455–465PubMedCrossRef Kim YH, Kim S, Kim KA et al (1999) Apoptosis of pancreatic B cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29:455–465PubMedCrossRef
29.
Zurück zum Zitat Wormald S, Hilton DJ (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279:821–824PubMedCrossRef Wormald S, Hilton DJ (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279:821–824PubMedCrossRef
30.
Zurück zum Zitat Krebs DL, Hilton DJ (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378–387PubMedCrossRef Krebs DL, Hilton DJ (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378–387PubMedCrossRef
31.
Zurück zum Zitat Lavens D, Ulrichts P, Catteeuw D et al (2007) The C-terminus of CIS defines its interaction pattern. Biochem J 401:257–267PubMedCrossRef Lavens D, Ulrichts P, Catteeuw D et al (2007) The C-terminus of CIS defines its interaction pattern. Biochem J 401:257–267PubMedCrossRef
32.
Zurück zum Zitat Karlsen AE, Rønn SG, Lindberg K et al (2001) Suppressor of cytokine signaling 3 (SOCS-3) protects beta-cells against interleukin-1beta- and interferon-gamma-mediated toxicity. Proc Natl Acad Sci U S A 98:12191–12196PubMedCrossRef Karlsen AE, Rønn SG, Lindberg K et al (2001) Suppressor of cytokine signaling 3 (SOCS-3) protects beta-cells against interleukin-1beta- and interferon-gamma-mediated toxicity. Proc Natl Acad Sci U S A 98:12191–12196PubMedCrossRef
33.
Zurück zum Zitat Frobose H, Groth Rønn S, Heding PE et al (2006) Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol 20:1587–1596PubMedCrossRef Frobose H, Groth Rønn S, Heding PE et al (2006) Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol 20:1587–1596PubMedCrossRef
34.
Zurück zum Zitat Ronn SG, Hansen JA, Lindberg K, Karlsen AE, Billestrup N (2002) The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells. Mol Endocrinol 16:2124–2134PubMedCrossRef Ronn SG, Hansen JA, Lindberg K, Karlsen AE, Billestrup N (2002) The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells. Mol Endocrinol 16:2124–2134PubMedCrossRef
35.
Zurück zum Zitat Parnaud G, Bosco D, Berrey T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91–100PubMedCrossRef Parnaud G, Bosco D, Berrey T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91–100PubMedCrossRef
36.
Zurück zum Zitat Friedrichsen BN, Richter HE, Hansen JA et al (2003) Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic β-cells. Mol Endocrinol 17:945–958PubMedCrossRef Friedrichsen BN, Richter HE, Hansen JA et al (2003) Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic β-cells. Mol Endocrinol 17:945–958PubMedCrossRef
37.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef
38.
Zurück zum Zitat Chen MC, Schuit F, Eizirik DL (1999) Identification of IL-1beta-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA. Diabetologia 42:1199–1203PubMedCrossRef Chen MC, Schuit F, Eizirik DL (1999) Identification of IL-1beta-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA. Diabetologia 42:1199–1203PubMedCrossRef
39.
Zurück zum Zitat Kutlu B, Darville MI, Cardozo AK, Eizirik DL (2003) Molecular regulation of monocyte chemoattractant protein-1 (MCP-1) expression in pancreatic β-cells. Diabetes 52:348–355PubMedCrossRef Kutlu B, Darville MI, Cardozo AK, Eizirik DL (2003) Molecular regulation of monocyte chemoattractant protein-1 (MCP-1) expression in pancreatic β-cells. Diabetes 52:348–355PubMedCrossRef
40.
Zurück zum Zitat Darville MI, Eizirik DL (2001) Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. Diabetes 50:1741–1748PubMedCrossRef Darville MI, Eizirik DL (2001) Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. Diabetes 50:1741–1748PubMedCrossRef
Metadaten
Titel
IL-1β-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells
verfasst von
M. L. B. Jacobsen
S. G. Rønn
C. Bruun
C. M. Larsen
D. L. Eizirik
T. Mandrup-Poulsen
N. Billestrup
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 2/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1199-1

Weitere Artikel der Ausgabe 2/2009

Diabetologia 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.